Multiple testing in the 'Canakinumab in atherosclerosis' trial: correction required?

Saved in:
Bibliographic Details
Published in:Clinical and experimental rheumatology 2017-05, Vol.35 Suppl 104 (2), p.24-24
Main Authors: Guzelant, Gul, Ongen, Zeki
Format: Article
Language:English
Subjects:
Antibodies, Monoclonal
Atherosclerosis
Humans
Interleukin-1beta
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 24
container_issue 2
container_start_page 24
container_title Clinical and experimental rheumatology
container_volume 35 Suppl 104
creator Guzelant, Gul
Ongen, Zeki
description
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1900128524</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1900128524</sourcerecordid><originalsourceid>FETCH-LOGICAL-p211t-2420d7aaf5f8cc894b0ad39050bfa4f90e7255f0ecf5bf7f3ba174399ab5d6913</originalsourceid><addsrcrecordid>eNo1UM1KxDAYzEFx19VXkNzWSyFJm6bxIrL4ByteVvBWvqSJRtO0m6QH394urpcZGIZhZk7QkpSSFQ2v3xfoPKUvQljNa3GGFqzhtG5EvUS7l8lnN3qDs0nZhQ_sAs6fBq83EODbhakHddBgFuOQtD-gS2ucowN_g_UQo9HZDQFHs59cNN3tBTq14JO5PPIKvT3c7zZPxfb18Xlzty1GRmkuWMVIJwAst43WjawUga6UhBNlobKSGME4t8Roy5UVtlRARVVKCYp3taTlCl3_5Y5x2E9z_7Z3SRvvIZhhSi2VhNB5K6tm69XROqnedO0YXQ_xp_1_ovwFsXlaRQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1900128524</pqid></control><display><type>article</type><title>Multiple testing in the 'Canakinumab in atherosclerosis' trial: correction required?</title><source>Freely Accessible Science Journals</source><creator>Guzelant, Gul ; Ongen, Zeki</creator><creatorcontrib>Guzelant, Gul ; Ongen, Zeki</creatorcontrib><identifier>ISSN: 0392-856X</identifier><identifier>PMID: 28516876</identifier><language>eng</language><publisher>Italy</publisher><subject>Antibodies, Monoclonal ; Atherosclerosis ; Humans ; Interleukin-1beta</subject><ispartof>Clinical and experimental rheumatology, 2017-05, Vol.35 Suppl 104 (2), p.24-24</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28516876$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Guzelant, Gul</creatorcontrib><creatorcontrib>Ongen, Zeki</creatorcontrib><title>Multiple testing in the 'Canakinumab in atherosclerosis' trial: correction required?</title><title>Clinical and experimental rheumatology</title><addtitle>Clin Exp Rheumatol</addtitle><subject>Antibodies, Monoclonal</subject><subject>Atherosclerosis</subject><subject>Humans</subject><subject>Interleukin-1beta</subject><issn>0392-856X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNo1UM1KxDAYzEFx19VXkNzWSyFJm6bxIrL4ByteVvBWvqSJRtO0m6QH394urpcZGIZhZk7QkpSSFQ2v3xfoPKUvQljNa3GGFqzhtG5EvUS7l8lnN3qDs0nZhQ_sAs6fBq83EODbhakHddBgFuOQtD-gS2ucowN_g_UQo9HZDQFHs59cNN3tBTq14JO5PPIKvT3c7zZPxfb18Xlzty1GRmkuWMVIJwAst43WjawUga6UhBNlobKSGME4t8Roy5UVtlRARVVKCYp3taTlCl3_5Y5x2E9z_7Z3SRvvIZhhSi2VhNB5K6tm69XROqnedO0YXQ_xp_1_ovwFsXlaRQ</recordid><startdate>20170501</startdate><enddate>20170501</enddate><creator>Guzelant, Gul</creator><creator>Ongen, Zeki</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20170501</creationdate><title>Multiple testing in the 'Canakinumab in atherosclerosis' trial: correction required?</title><author>Guzelant, Gul ; Ongen, Zeki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p211t-2420d7aaf5f8cc894b0ad39050bfa4f90e7255f0ecf5bf7f3ba174399ab5d6913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Antibodies, Monoclonal</topic><topic>Atherosclerosis</topic><topic>Humans</topic><topic>Interleukin-1beta</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Guzelant, Gul</creatorcontrib><creatorcontrib>Ongen, Zeki</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical and experimental rheumatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Guzelant, Gul</au><au>Ongen, Zeki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multiple testing in the 'Canakinumab in atherosclerosis' trial: correction required?</atitle><jtitle>Clinical and experimental rheumatology</jtitle><addtitle>Clin Exp Rheumatol</addtitle><date>2017-05-01</date><risdate>2017</risdate><volume>35 Suppl 104</volume><issue>2</issue><spage>24</spage><epage>24</epage><pages>24-24</pages><issn>0392-856X</issn><cop>Italy</cop><pmid>28516876</pmid><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0392-856X
ispartof Clinical and experimental rheumatology, 2017-05, Vol.35 Suppl 104 (2), p.24-24
issn 0392-856X
language eng
recordid cdi_proquest_miscellaneous_1900128524
source Freely Accessible Science Journals
subjects Antibodies, Monoclonal
Atherosclerosis
Humans
Interleukin-1beta
title Multiple testing in the 'Canakinumab in atherosclerosis' trial: correction required?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T12%3A41%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multiple%20testing%20in%20the%20'Canakinumab%20in%20atherosclerosis'%20trial:%20correction%20required?&rft.jtitle=Clinical%20and%20experimental%20rheumatology&rft.au=Guzelant,%20Gul&rft.date=2017-05-01&rft.volume=35%20Suppl%20104&rft.issue=2&rft.spage=24&rft.epage=24&rft.pages=24-24&rft.issn=0392-856X&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E1900128524%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p211t-2420d7aaf5f8cc894b0ad39050bfa4f90e7255f0ecf5bf7f3ba174399ab5d6913%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1900128524&rft_id=info:pmid/28516876&rfr_iscdi=true